Clinical trial · Interventional
Auditory Brainstem Implant (ABI) in Pediatric Non-Neurofibromatosis Type 2 Subjects
Study of the Nucleus 24 and ABI541 Auditory Brainstem Implants in Pediatric Non-Neurofibromatosis Type 2
NCT01864291CI-TRIAL-00045378ABIterminatedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Closed by IRB
Summary
Brief summary (as posted)
The purpose of this research study is to determine whether Auditory Brainstem Implant (ABI) can improve hearing in children who are deaf and cannot receive a cochlear implants.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bilateral Hearing Loss for Causes Other Than Tumors | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Nucleus 24 (discontinued) and ABI541 Auditory Brainstem Implants (ABI) | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Non-NF2 ABI surgery
- description
- All subjects will be part of a single arm involving placement of the ABI541 Auditory Brainstem Implant (ABI) device. The Nucleus 24 was discontinued and is no longer available.
- interventionNames
- Device: Nucleus 24 (discontinued) and ABI541 Auditory Brainstem Implants (ABI)
Primary outcomes (1)
- measure
- Number of Participants With Major or Minor ABI Complications
- timeFrame
- 1 year from date of surgery
- description
- We will track any major and minor complications peri-operatively and post-operatively in all study participants. Major complications include mortality, cerebellar contusion, facial palsy, meningitis, lower cranial neuropathy, hydrocephalus, pseudomeningocele and CSF leak. Minor complications include transient hydrocephalus, wound seroma, minor infections, balance problems, transient nerve palsies, transient dysphonia or difficulty swallowing, headache, flap problems, and non-auditory side effects. These complications will be tracked through serial clinical exams as well as patient recorded questionnaires to determine the safety profile of ABI surgery.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Months
- Maximum age
- 17 Years
Show eligibility criteria text
Inclusion Criteria:
1. Pre-linguistic hearing loss (birth-5 yrs.; age at ABI implantation 18 months-5yrs) with both:
1. MRI +/- CT evidence of one of the following:
* Cochlear nerve deficiency
* Cochlear aplasia or severe hypoplasia
* Severe inner ear malformation
* Post-meningitis ossification
2. When a cochlea is present or patent with a normally appearing cochlear nerve, lack of significant benefit from CI despite consistent use (\>6 mo.)
* No or limited speech perception ability (limited to pattern perception on closed set testing materials using the CI)
* Lack of progress in auditory skills development
2. Post-linguistic hearing loss (\<18 yrs. of age) with both:
1. Loss or lack of benefit from appropriate CI without the possibility for revision or contralateral implantation. Examples might include:
* Post-meningitis ossification
* Bilateral temporal bone fractures with cochlear nerve avulsion
* Failed revision CI without benefit
2. Previously developed open set speech perception and auditory-oral language skills
3. No medical contraindications
4. Willing to receive the appropriate meningitis vaccinations
5. No or limited cognitive/developmental delays which would be expected to interfere with the child's ability to cooperate in testing and/or programming of the device, in developing speech and oral language, or which would make an implant and subsequent emphasis on aural/oral communication not in the child's best interest
6. Strong family support including language proficiency of the parent(s) in the child's primary mode of communication as well as written and spoken English.
7. Reasonable expectations from parents including a thorough understanding:
* of potential benefits and limitations of ABI
* of parental role in rehabilitation
* that the child may not develop spoken language as a primary communication mode or even sufficient spoken language to make significant academic progress in an aural/oral environment
8. Involvement in an educational program that emphasizes development of auditory skills with or without the use of supplementary visual communication.
9. Able to comply with study requirements including travel to investigation sites and clinic visits.
10. Informed consent for the procedure from the child's parents.
Exclusion Criteria:
1. Pre- or post-linguistic child currently making significant progress with CI - This will be considered if a child is progressing along the expected speech reception hierarchy (SRI-Q) as detailed by Wang et al (50). Even for the very young children (18 months of age with 6 months of use), nearly all children with a good auditory signal from their CI will have reached ceiling effects on the IT-MAIS and have pattern perception beyond chance using the ESP (50). Moreover, there will evidence of improvement in these metrics over time.
2. MRI evidence of one of the following:
* normal cochlea and cochlear nerves or NF2
* brainstem or cortical anomaly that makes implantation unfeasible
3. Clear surgical reason for poor CI performance that can be remediated with revision CI or contralateral surgery rather than ABI.
4. Intractable seizures or progressive, deteriorating neurological disorder
5. Unable to participate in behavioral testing and mapping with their CI. If this appears to be an age effect, ABI will be delayed until we can be assured that the child will be able to participate, as reliable objective measures of mapping are currently not available for mapping these devices.
6. Lack of potential for spoken language development. This will be considered the case when evidence of the following exist:
* Severe psychomotor retardation, autism, cerebral palsy, or developmental delays beyond speech that would preclude usage of the device and oral educational development. Autism is a special case where there is the potential for delayed presentation. When early signs are considered present, we will request a comprehensive developmental assessment for further evaluation prior to considering routine evaluation.
7. Unable to tolerate general anesthesia (cardiac, pulmonary, bleeding diathesis, etc.).
8. Need for brainstem irradiation
9. Unrealistic expectations on the part of the subject/family regarding the possible benefits, risks and limitations that are inherent to the procedure and prosthetic device.
10. Unwilling to sign the informed consent.
11. Unwilling to make necessary follow-up appointments.References
Publications (7)
- BACKGROUNDColletti V, Shannon RV, Carner M, Veronese S, Colletti L. Complications in auditory brainstem implant surgery in adults and children. Otol Neurotol. 2010 Jun;31(4):558-64. doi: 10.1097/MAO.0b013e3181db7055. PMID 20393378
- BACKGROUNDSennaroglu L, Ziyal I, Atas A, Sennaroglu G, Yucel E, Sevinc S, Ekin MC, Sarac S, Atay G, Ozgen B, Ozcan OE, Belgin E, Colletti V, Turan E. Preliminary results of auditory brainstem implantation in prelingually deaf children with inner ear malformations including severe stenosis of the cochlear aperture and aplasia of the cochlear nerve. Otol Neurotol. 2009 Sep;30(6):708-15. doi: 10.1097/MAO.0b013e3181b07d41. PMID 19704357
- BACKGROUNDChoi JY, Song MH, Jeon JH, Lee WS, Chang JW. Early surgical results of auditory brainstem implantation in nontumor patients. Laryngoscope. 2011 Dec;121(12):2610-8. doi: 10.1002/lary.22137. PMID 22109761
- BACKGROUNDColletti V, Shannon R, Carner M, Veronese S, Colletti L. Outcomes in nontumor adults fitted with the auditory brainstem implant: 10 years' experience. Otol Neurotol. 2009 Aug;30(5):614-8. doi: 10.1097/MAO.0b013e3181a864f2. PMID 19546832
- BACKGROUNDColletti V, Carner M, Miorelli V, Guida M, Colletti L, Fiorino F. Auditory brainstem implant (ABI): new frontiers in adults and children. Otolaryngol Head Neck Surg. 2005 Jul;133(1):126-38. doi: 10.1016/j.otohns.2005.03.022. PMID 16025066
- BACKGROUNDColletti V. Auditory outcomes in tumor vs. nontumor patients fitted with auditory brainstem implants. Adv Otorhinolaryngol. 2006;64:167-185. doi: 10.1159/000094651. PMID 16891842
- BACKGROUNDColletti L, Zoccante L. Nonverbal cognitive abilities and auditory performance in children fitted with auditory brainstem implants: preliminary report. Laryngoscope. 2008 Aug;118(8):1443-8. doi: 10.1097/MLG.0b013e318173a011.